Markers of instability in high-risk carotid plaques are reduced by statins
Hagen Kunte1, Nicola Amberger, Markus Alexander Busch
1Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany. hagen.kunte@charite.de
Insights
Statins appear to stabilize carotid atherosclerotic plaques by reducing macrophage infiltration and matrix metalloproteinase-9 (MMP-9) expression, key indicators of plaque instability. This study confirms these markers and supports statins
Area of Science:
- Cardiovascular Research
- Immunology
- Biomedical Engineering
Background:
- Macrophage infiltration and matrix metalloproteinase-9 (MMP-9) expression are established markers of high-risk, unstable atherosclerotic carotid plaques.
- Statins are associated with reduced stroke risk and improved plaque stability, but the underlying mechanisms remain debated.
Purpose of the Study:
- To investigate the association between statin use and markers of carotid plaque instability, specifically macrophage infiltration and MMP-9 expression.
- To elucidate the mechanism by which statins may confer plaque stability in patients with carotid artery stenosis.
Main Methods:
- Retrospective analysis of 94 patients with internal carotid artery stenosis undergoing carotid endarterectomy.
- Quantitative immunohistochemical analysis of excised plaques to determine macrophage and MMP-9 area percentages.
- Univariate and multivariate analyses to examine associations between plaque markers, statin use, and cerebrovascular disease.
Main Results:
- Symptomatic carotid plaques showed significantly higher macrophage and MMP-9 area percentages compared to asymptomatic plaques (P < .0005).
- Statin-treated patients exhibited significantly lower macrophage and MMP-9 area percentages than untreated patients (P = .01 and P < .0005, respectively).
- These associations remained significant after controlling for symptomatic disease and other confounders in multivariable analysis.
Conclusions:
- Macrophage and MMP-9 area percentages are confirmed as reliable indicators of carotid plaque instability.
- The findings provide robust evidence that statins stabilize atherosclerotic plaques by reducing inflammatory markers, supporting their role in preventing stroke.
Background:
Macrophage infiltration and expression of matrix metalloproteinase-9 (MMP-9) are markers of high-risk atherosclerotic carotid plaques and strong indicators of plaque instability. Use of statins is associated with a decreased risk of stroke and reportedly improves stability of atherosclerotic plaques, but available data addressing the mechanism of this effect are conflicting.
Methods:
We retrospectively analyzed data from 94 consecutive patients with internal carotid artery stenosis who underwent carotid endarterectomy. Excised plaques underwent systematic quantitative immunohistochemical analysis to determine the percentage of macrophage area and the percentage of MMP-9 area. Associations between percentage of macrophage area and percentage of MMP-9 area and use of statins and cerebrovascular disease were examined by univariate and multivariate analysis.
Results:
We found significantly higher values of percentage of macrophage area and of MMP-9 area in recently symptomatic (n = 26) compared with asymptomatic (n = 68) internal carotid artery stenoses: median (IQR) percentage of macrophage area was 2.29 (1.53-4.129) vs 0.53 (0.27-0.96) and percentage of MMP-9 area was 0.61 (0.36-0.89) vs 0.08 (0.02-0.27; both P < .0005). Patients treated with statins (n = 49) showed lower percentage values of macrophage area and MMP-9 area than untreated patients: the percentage of macrophage area was 0.54 (0.31-1.18) vs 1.03 (0.57-2.08; P = .01) and percentage of MMP-9 area was 0.06 (0.02-0.22) vs 0.36 (0.16-0.62; P < .0005). These associations between statin treatment and percentages of macrophage area and MMP-9 area did not change after controlling for symptomatic cerebrovascular disease and the effects of other potential confounders in multivariable analysis.
Conclusions:
Our results confirm the value of percentage of macrophage area and percentage of MMP-9 area as markers of plaque instability and provide further evidence to support the hypothesis that statins reduce inflammatory responses and thereby stabilize carotid atherosclerotic plaques.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction

